Angiotech Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)
03 März 2008 - 10:00PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Expires:
January 31, 2008
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
WEST COAST ASSET MANAGEMENT INC
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
2/15/2008
|
3. Issuer Name
and
Ticker or Trading Symbol
ANGIOTECH PHARMACEUTICALS INC [ANPI]
|
(Last)
(First)
(Middle)
2151 ALESSANDRO DR, STE 100
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
___
X
___ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Street)
VENTURA, CA 93001
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_
X
_ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Angiotech Pharmaceuticals, Inc.
|
10003225
|
I
|
See footnote
(1)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
(
1)
|
The Reporting Persons may be deemed to be indirect beneficial owners of the shares because WCAM has the power to vote the shares pursuant to investor advisor agreements with the record owners. 2457050 shares are held in trust accounts, 655125 shares are held in IRA accounts, 2586500 shares are held in Foundation accounts, 60600 shares are held in corporate accounts, 3611400 shares are held in high net worth individuals' accounts, 228150 shares are held in LLC accounts, 219900 shares are held in LP accounts, and 184500 shares are held in profit sharing accounts (managed by WCAM).
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
WEST COAST ASSET MANAGEMENT INC
2151 ALESSANDRO DR
STE 100
VENTURA, CA 93001
|
|
X
|
|
|
Orfalea Paul J
2151 ALESSANDRO DRIVE
SUITE 100
VENTURA, CA 93001
|
|
X
|
|
|
Helfert Lance W
2151 ALESSANDRO DRIVE
SUITE 100
VENTURA, CA 93001
|
|
X
|
|
|
Lowe R Atticus
2151 ALESSANDRO DRIVE
SUITE 100
VENTURA, CA 93001
|
|
X
|
|
|
Signatures
|
/s/ Linda Schuman as Attorney-In-Fact
|
|
3/3/2008
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals Inc News-Artikel